2014
DOI: 10.1136/jnnp-2014-308584
|View full text |Cite
|
Sign up to set email alerts
|

Levetiracetam versus phenytoin for seizure prophylaxis during and early after craniotomy for brain tumours: a phase II prospective, randomised study

Abstract: UMIN13971.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
57
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 72 publications
(59 citation statements)
references
References 30 publications
2
57
0
Order By: Relevance
“…In past studies, levetiracetam was described as a potentially beneficial alternative to conventional AEDs in patients with brain tumors, which is based on comparatively rare drug interactions and side effects [34, 35]. Therefore, this drug is increasingly used in the neurosurgical context, allowing formation of a subgroup large enough for statistically meaningful analysis in the present study (Table 1).…”
Section: Discussionmentioning
confidence: 97%
“…In past studies, levetiracetam was described as a potentially beneficial alternative to conventional AEDs in patients with brain tumors, which is based on comparatively rare drug interactions and side effects [34, 35]. Therefore, this drug is increasingly used in the neurosurgical context, allowing formation of a subgroup large enough for statistically meaningful analysis in the present study (Table 1).…”
Section: Discussionmentioning
confidence: 97%
“…In a small randomized open-label trial comparing levetiracetam to pregabalin in patients with primary BTs, retention rates were 59% in the levetiracetam group, and 41% in the pregabalin group [27]. In a randomized, open-label trial comparing levetiracetam to phenytoin, the incidence of seizures was significantly less in the levetiracetam group (1.4%) than in the phenytoin group (15.1%) [28]. Among all first-choice AEDs in our patient population, the most favorable prognostic factor for time in therapy, prior to its substitution due to SE, seems to have been treatment with a non-EI-AED, particularly with levetiracetam.…”
Section: Discussionmentioning
confidence: 99%
“…Most of the patients had gliomas, and only a few meningioma patients, were included (seven of 146). In this study, AEDs were given for 7 days after surgery [19]. Another randomized controlled study compared phenytoin and levetiracetam using a different AED prophylactic strategy, as patients took AEDs for 3 months.…”
Section: Prophylactic Aed Treatment In Short and Long Termmentioning
confidence: 98%